🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 21 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/08/2023 | 237,45 | 239,72 | 236,80 | 237,80 | +0,27% | 1,23% | 263.000 |
| 10/08/2023 | 235,49 | 238,32 | 235,33 | 237,15 | +0,91% | 1,27% | 206.000 |
| 09/08/2023 | 236,32 | 240,27 | 233,73 | 235,01 | -0,75% | 2,77% | 206.200 |
| 08/08/2023 | 237,80 | 240,53 | 235,08 | 236,78 | -0,43% | 2,29% | 304.400 |
| 07/08/2023 | 236,37 | 239,12 | 234,06 | 237,80 | +0,60% | 2,14% | 349.900 |
| 04/08/2023 | 232,02 | 238,93 | 231,87 | 236,37 | +1,94% | 3,04% | 436.300 |
| 03/08/2023 | 242,28 | 243,78 | 230,00 | 231,87 | -3,73% | 5,69% | 751.900 |
| 02/08/2023 | 260,01 | 261,54 | 240,58 | 240,85 | +0,30% | 8,06% | 950.700 |
| 01/08/2023 | 242,71 | 243,16 | 238,74 | 240,13 | -1,07% | 1,82% | 246.800 |
| 31/07/2023 | 245,15 | 245,15 | 239,83 | 242,72 | -1,00% | 2,17% | 339.900 |
| 28/07/2023 | 244,12 | 246,73 | 242,11 | 245,17 | +0,99% | 1,89% | 261.300 |
| 27/07/2023 | 243,72 | 243,72 | 241,29 | 242,77 | -0,03% | 1,00% | 197.200 |
| 26/07/2023 | 244,60 | 244,60 | 241,02 | 242,84 | -0,72% | 1,46% | 294.900 |
| 25/07/2023 | 243,91 | 246,36 | 243,91 | 244,60 | -0,46% | 1,00% | 287.600 |
| 24/07/2023 | 248,58 | 250,43 | 245,71 | 245,73 | -1,01% | 1,90% | 354.000 |
| 21/07/2023 | 245,63 | 249,08 | 243,71 | 248,24 | +1,60% | 2,19% | 238.300 |
| 20/07/2023 | 243,87 | 246,77 | 242,54 | 244,34 | +0,89% | 1,73% | 553.600 |
| 19/07/2023 | 239,16 | 242,46 | 238,22 | 242,19 | +1,80% | 1,77% | 214.200 |
| 18/07/2023 | 235,70 | 238,58 | 235,33 | 237,91 | +1,56% | 1,38% | 245.800 |
| 17/07/2023 | 232,00 | 236,99 | 231,23 | 234,26 | +0,97% | 2,48% | 286.900 |
| 14/07/2023 | 230,64 | 233,32 | 229,93 | 232,00 | +0,95% | 1,47% | 263.200 |
| 13/07/2023 | 230,57 | 234,39 | 229,36 | 229,81 | -0,04% | 2,18% | 305.000 |
| 12/07/2023 | 223,99 | 232,54 | 223,50 | 229,91 | +3,73% | 4,04% | 436.800 |
| 11/07/2023 | 223,81 | 224,13 | 219,86 | 221,65 | -0,67% | 1,91% | 240.900 |
| 10/07/2023 | 211,58 | 223,85 | 211,58 | 223,14 | +5,34% | 5,80% | 718.500 |
| 07/07/2023 | 213,00 | 214,16 | 211,25 | 211,82 | -0,55% | 1,37% | 313.200 |
| 06/07/2023 | 219,07 | 219,34 | 212,58 | 213,00 | -2,93% | 3,09% | 350.300 |
| 05/07/2023 | 223,07 | 223,74 | 218,72 | 219,43 | -1,93% | 2,25% | 349.100 |
| 03/07/2023 | 220,24 | 224,95 | 219,95 | 223,75 | +1,36% | 2,27% | 188.700 |
| 30/06/2023 | 220,97 | 222,68 | 218,71 | 220,75 | +0,44% | 1,80% | 293.000 |